Throughout this webinar, our experts and client guest speaker, Ian Mussen, Head of Supply Chain EMEA, Novartis Gene Therapies share valuable insight into the key considerations for a successful Gene Therapy product launch.

The presenters review areas such as developing bespoke packaging processes to facilitate in most cases, Ultra Low Temperature handling requirements and the various Just in Time supply chain models. Ian joins the Almac team to share his real-life experience of successfully launching Zolgensma onto the EU market including the approach Novartis Gene Therapies took to ensure a smooth launch and what lessons were learnt along the way.

Speakers: Robert O’Brien, Head of Technical Support and Ian Mussen, Head of Supply Chain EMEA, Novartis Gene Therapies